Surveys reveal 87% of experts support increased R&D spending in the U.S., indicating strong public backing.
Abstract Research and development (R&D) is widely regarded as a crucial factor in driving improvements in living standards, health, and life expectancy. Quantifying the social returns to government R&D spending and assessing whether citizens value such spending — two inputs that directly shape R&D budget decisions — are central concerns for researchers and policymakers. In light of recent and substantial reductions in U.S. federal R&D spending, evidence on these inputs is more important than ever. Using surveys of experts (N approx 115) and nationally representative U.S. samples (N = 2,008), our paper provides new evidence on these inputs. We find that 87% of experts judge that the social benefits from increasing U.S. government R&D spending at the margin exceed the costs, with the median expert expecting benefits between $2 - $2.4 per dollar invested. Furthermore, approximately 83% of experts and 81% of citizens support increasing R&D spending. These results imply that increases in U.S. federal government R&D spending are both valuable and politically feasible. Experts systematically underestimate citizens' support for R&D spending, highlighting scope for correcting such misperceptions to improve the alignment between citizens' views and policies.
No takes yet. Share an insight, caveat, or question.
Toma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: